We reviewed the approaches State legislators took to offset the effect of defunding CSRs. Here are our observations of activity across the country.

Principal, Oliver Wyman
Practice Leader, Oliver Wyman Actuarial Consulting

Why a focus on the provider is needed to achieve 4 or 5 Stars.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Our new advice for the Blues, who are in a formative period as market trends create both sizable risk and sizable opportunity.

Principal, Oliver Wyman Actuarial Consulting
Global Head, Health Services, Oliver Wyman
Principal, Oliver Wyman

Advice on how the healthcare industry can address the pharmaceutical cost problem.

Principal, Oliver Wyman

Why are premiums rising amidst the Affordable Care Act market? It's not because of medical trends, says Oliver Wyman's 2018 Carrier Trend Survey.

Partner, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman Actuarial Consulting

Insights in your inbox

Subscribe

Adaptability is key for the future healthcare workforce. But those organizations interested in outsourcing their talent need these strategic tools to remain competitive.

Principal, Oliver Wyman

Pregnant women are often positioned with taking care of themselves independently in between physician visits. Here's how a new support system empowers women's health.

Senior Vice President, Enterprise Research and Development, UnitedHealth Group

Here’s more on how proposed modifications to CMS’ Advance Notice Summary may affect reimbursement, payment growth rates, and regulation.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting
Principal, Oliver Wyman Actuarial Consulting

In light of breaking news, the pharma value chain is definitely ripe for disruption. Here's how health plans, employers, and drug companies can adjust to the new normal.

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

Cybersecurity is still a foreign concept for many executives looking to avoid the next WannaCry. This new report from Marsh & McLennan and FireEye shares five cyber risk solutions for business leaders.

Chief Executive Officer, FireEye
Executive Vice President and General Counsel, Marsh & McLennan Companies, Inc

Insights in your inbox

Subscribe
Load More